메뉴 건너뛰기




Volumn 3, Issue 3, 2010, Pages 226-228

GWAS applied to heart failure bigger will be better ... eventually

Author keywords

Editorials; Genetics; Heart failure; Prognosis; Risk factors

Indexed keywords

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; EDITORIAL; GENE DELETION; GENETIC ASSOCIATION; HEART FAILURE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC DYSFUNCTION; GENETICS; GENOTYPE;

EID: 77955884348     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.110.957324     Document Type: Editorial
Times cited : (3)

References (12)
  • 5
    • 0030198578 scopus 로고    scopus 로고
    • The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure
    • Andersson B, Sylvén C. The DD genotype of the angiotensin- converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 1996;28:162-167.
    • (1996) J Am Coll Cardiol , vol.28 , pp. 162-167
    • Andersson, B.1    Sylvén, C.2
  • 6
    • 0033730995 scopus 로고    scopus 로고
    • A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure
    • Börjesson M, Magnusson Y, Hjalmarson A, Andersson B. A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J. 2000;21:1853-1858.
    • (2000) Eur Heart J , vol.21 , pp. 1853-1858
    • Börjesson, M.1    Magnusson, Y.2    Hjalmarson, A.3    Andersson, B.4
  • 7
    • 8144221236 scopus 로고    scopus 로고
    • Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure
    • McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. J Am Coll Cardiol. 2004;44:2019-2026.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 2019-2026
    • McNamara, D.M.1    Holubkov, R.2    Postava, L.3    Janosko, K.4    MacGowan, G.A.5    Mathier, M.6    Murali, S.7    Feldman, A.M.8    London, B.9
  • 11
    • 67849121517 scopus 로고    scopus 로고
    • Bloodomics and cardiogenics consortia: The discovery of genes implicated in myocardial infarction
    • Ouwehand WH. Bloodomics and cardiogenics consortia: the discovery of genes implicated in myocardial infarction. J Thromb Haemost. 2009;7: 305-307.
    • (2009) J Thromb Haemost , vol.7 , pp. 305-307
    • Ouwehand, W.H.1
  • 12
    • 70450185104 scopus 로고    scopus 로고
    • Racial differences in heart failure therapeutics
    • Ishizawar D, Yancy C. Racial differences in heart failure therapeutics. Heart Fail Clin. 2010;6:65-74.
    • (2010) Heart Fail Clin , vol.6 , pp. 65-74
    • Ishizawar, D.1    Yancy, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.